PortViewPortView
SELLAS Life Sciences logo

SELLAS Life Sciences (SLS) Stock Analysis

NASDAQHealthcareBiotechnology

$13.73+3.87%
1-year price historyRange $1.39 – $15.46
52-week range$13.73
$1.39$15.88

What SELLAS Life Sciences does

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

Key metrics

Market cap
$2.55B
P/E (TTM)
-65.39
EPS (TTM)
$-0.21
Beta
2.49
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$12.54
200-day avg
$6.62
52-week high
$15.88
52-week low
$1.39
CEO
Angelos Stergiou

ETFs linked to SLS

Broad-market and Healthcare sector ETFs an investor holding SELLAS Life Sciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SLS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SLS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for SELLAS Life Sciences?
SELLAS Life Sciences trades under the ticker SLS on NASDAQ.
Which exchange is SLS listed on?
SLS is listed on NASDAQ.
What sector does SELLAS Life Sciences operate in?
SELLAS Life Sciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SLS in a portfolio?
PortView shows SLS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.